ÂÜÀòÂÒÂ×

Diya joined Abingworth in June 2021 from L.E.K. Consulting. She works with the transatlantic investment team, in particular the Clinical Co-Development team, to evaluate new investment opportunities and support existing investments.

As a Consultant with L.E.K. Consulting’s Life Sciences practice, Diya advised pharmaceutical, biotech, and early and late-stage buyside clients on a range of projects including corporate strategy, and clinical and commercial opportunity assessments.

Diya holds a Ph.D. in Clinical Neuropharmacology from Imperial College London and a degree in Pharmacology from University College London.